Request that the Commissioner of Food and Drugs amend the sulfite warning requirement in 21 C.F.R. 201.22 for sulfite-containing epinephrine for injection for use in emergency situations, in order to remove misleading information and acknowledge the current availability of approved epinephrine products that do not contain sulfite. | Federal Regulations · Congress.wiki